Skip to main content
# Title Department Research Year
101 Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice Department of Pharmacology 2022
102 New 1, 2, 4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity Department of Pharmaceutical Organic Chemistry 2022
103 Diverse Glycosides from Gardenia latifolia with Antiviral Activity and Chemosystematic Significance Department of Pharmacognosy 2022
104 Electrochemical sensing of copper-chelator D- penicillamine based on complexation with gold nanoparticles modified copper based-metal organic frameworks Department of Pharmaceutical Analytical Chemistry 2022
105 Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties Department of Pharmaceutical Organic Chemistry 2022
106 Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 complex from SARS-CoV-2. 2022
107 A Novel C Fe Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma Department of Industrial Pharmacy 2022
108 Microwave-Assisted Synthesis, Biological Activity Evaluation, Molecular Docking, and ADMET Studies of Some Novel Pyrrolo [2,3-b] Pyrrole Derivatives Department of Medicinal Chemistry 2022
109 Elegant, Flexible Vesicular Nanocarriers for the Efficient Skin Delivery of Topically Applied Drugs Department of Pharmaceutics 2022
110 Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAFV600E 2022